<
new post
StocksRunner logo
mail
search
 
menu
 
Ascendis Pharma A/S
$234.54
-0.19%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

ASND Stock Analysis & IQ Rating | Ascendis Pharma A/S

 
 

ASND

 

Ascendis Pharma A/S

$234.54

 
-$0.45 | -0.19%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$242
 
 
MKT CAP
$14.53B
 
52W Low
$124.06
 
 
VOL
$56.77K
 
P/E Ratio
N/A
 
 
AVG VOL
$765.79K
 
RSI
60.16
 
 
TREND
Uptrend
 
 
 

ASND Stock IQ

 
lock  Login to see Ascendis Pharma A/S (ASND) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

ASND Target Price

 
 
 

Strengths

 
 

ASND Rewards

 Upgraded on attractively valued

ASND Rewards

 Earnings are forecast to grow

ASND Rewards

 Outperform the market

 
 

ASND Price Performance

 
 

$222.45   (+5.43%)

$212.33   (+10.46%)

$204.11   (+14.91%)

$150.31   (+56.04%)

 
 
1year
6month
3month
1month

ASND Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

ASND Earnings Sentiment Below analyst estimate

Rating

×

Rating

ASND Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ASND Future Sentiment Earnings are forecast to grow
ASND Future Sentiment Outperform the market
ASND Analysts Opinion

ASND Analysts opinion is negative and it remained unchanged from the past 3 months

ASND Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

82%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
ASND Street Sentiment

ASND Street Sentiment is extremely bullish and have positive views on the near-term outlook

ASND Risk Level

ASND has Low risk level

ASND Risk Level
Low
LOW
HIGH

ASND Performance Sentiment

Sentiments overview associated with events and the stock performance

82%
Positive
14 out of 17
events present
18%
Negative
3 out of 17
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$215.80
Resistance Price
$238.80
Current Price Range
$234.99
$215.80
$238.80
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
7
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Jan 29, 2026

 

Reiterate

 

Buy

 

Wells Fargo

 

Jan 28, 2026

 

Initiate

 

Overweight

 

Barclays

 

Dec 12, 2025

 

Reiterate

 

Buy

 

Stifel

 

Nov 18, 2025

 

Reiterate

 

Outperform

 

Wedbush

 

Oct 18, 2025

 

Initiate

 

Buy

 

Raymond James

 
 
 
ASND Latest Analysis +
 
 
FAQ About ASND Stock Insights
 

What is ASND current stock price?

What are ASND stock strengths?

What is ASND Risk Level?

What is ASND market cap and volume?

What is ASND current Stock IQ?

Should I buy ASND stock right now?

Is ASND a Strong Buy right now?

What does a 'Strong Buy' rating mean for ASND?

What does a 'Strong Sell' rating mean for ASND?

What factors influence ASND's Stock IQ?

 
 
StocksRunner

Explore our ASND Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ASND Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ASND Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

ASND

 

Ascendis Pharma A/S

 
Set Alerts
 
 

Current Price

 

$234.54

 
-$0.45 | -0.19%
 
 
52W High
$242
 
 
MKT CAP
$14.53B
 
52W Low
$124.06
 
 
VOL
$56.77K
 
P/E Ratio
N/A
 
 
AVG VOL
$765.79K
 
RSI
60.16
 
 
TREND
Uptrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

ASND Price Performance

 
 

$222.45   (+5.43%)

$212.33   (+10.46%)

$204.11   (+14.91%)

$150.31   (+56.04%)

 
 
1year
6month
3month
1month
 

ASND Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

ASND Earnings Sentiment Below analyst estimate

Rating

×

Rating

ASND Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

Activity

×

Activity

Future

×

Future

ASND Future Sentiment Earnings are forecast to grow
ASND Future Sentiment Outperform the market
ASND Analysts Opinion

ASND Analysts opinion is negative and it remained unchanged from the past 3 months

ASND Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

82%
Consensus Rating
100%
Buy
Opinion
100%
Trend
Score
100%
Potential
Score
ASND Street Sentiment

ASND Street Sentiment is extremely bullish and have positive views on the near-term outlook

ASND Risk Level

ASND has Low risk level

ASND Risk Level
Low
LOW
HIGH
ASND Performance Sentiment
Sentiments overview associated with events and the stock performance.
82%
Positive
14 out of 17
events present
18%
Negative
3 out of 17
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$215.80
Resistance Price
$238.80
Current Price Range
$234.99
$215.80
$238.80
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
7
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Jan 29, 2026
Reiterate
Buy
Wells Fargo
Jan 28, 2026
Initiate
Overweight
Barclays
Dec 12, 2025
Reiterate
Buy
Stifel
Nov 18, 2025
Reiterate
Outperform
Wedbush
Oct 18, 2025
Initiate
Buy
Raymond James
 
 
 
 

ASND Stock IQ

 
 
 
lock  Login to unlock Ascendis Pharma A/S (ASND) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

ASND Rewards

 Upgraded on attractively valued

ASND Rewards

 Earnings are forecast to grow

ASND Rewards

 Outperform the market

 
 
 

ASND Latest Analysis

 
 
 

Ascendis Pharma (ASND) Revenue Nearly Doubles to €720M in 2025 Fueled by Core Product Growth. Ascendis Pharma (NASDAQ:ASND) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 11 Ascendis Pharma reported that it nearly doubled its total revenue for 2025 to €720 million fueled by the rapid global adoption of its core endocrinology products. Q4 was particularly significant as the company achieved [….]

 

Fri Feb 20, 2026

$224.88 | -2.26%
 
Activity
Potential

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2025 Earnings Call Transcript. Ascendis Pharma A/S (NASDAQ:ASND) Q4 2025 Earnings Call Transcript February 11 2026 Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-0.76815 EPS expectations were $-0.06. Operator: At this time participants are in listen-only mode. Thank you for standing by and welcome to the Ascendis Pharma A/S Fourth Quarter 2025 Earnings Conference Call. After [….]

 

Thu Feb 12, 2026

$218.10 | -1.53%
 
Earnings

Ascendis Pharma FY 2025 Results: More Than A Takeover Story.

 

Thu Feb 12, 2026

$218.10 | -1.53%
 
Activity

A Glimpse of Ascendis Pharmas Earnings Potential. Ascendis Pharma (NASDAQ:ASND) is gearing up to announce its quarterly earnings on Wednesday 2026-02-11. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Ascendis Pharma will report an The market awaits Ascendis Pharma'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand th

 

Tue Feb 10, 2026

$224.05 | +0.91%
 
Earnings
Earnings
Momentum
 
 
 
 
 
StocksRunner

Discover ASND Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ASND. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ASND Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ASND Stock trends

ASND Stock performance

ASND Stock analysis

ASND investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

ASND Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ASND

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing ASND

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.